You can buy or sell GBT and other stocks, options, and ETFs commission-free!
Global Blood Therapeutics, Inc. Common Stock, also called Global Blood Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. The listed name for GBT is Global Blood Therapeutics, Inc. Common Stock.
Ted W. Love
South San Francisco, California
52 Week High
52 Week Low
— per share
Expected Feb 24, After Hours